Christine Meidinger joins the company to lead global commercialization efforts across multiple industries
MINNEAPOLIS (October 2, 2024) Seldox, a biotechnology company specializing in the prevention of biofilm formation using molecular additives of redox active selenium and offering solutions to multiple industries, announced today new leadership as Christine Meidinger becomes the chief executive officer. Meidinger joins the team as the company prepares for fast-paced growth. Seldox’s technology is non-toxic, non-leaching, and effective in extremely low concentration with microbial inhibition rates up to 99.999999%. SELDOX is ideal for integration into products where prevention of microbes and biofilm result in better performance and safer outcomes.
Meidinger has a successful record as an executive and leader, bringing over 20 years of industry specific experience to the Seldox team. She has led high-performing teams at start-ups and mid-sized companies, including most recently serving as the chief operations officer at VitalPath, a private company that finds complex solutions for medical device partners. During her career, she has successfully launched global operations, implemented sales operations, revised new product introduction plan through value mapping and owned profit/loss of $100M.
“This is an important time for Seldox as the company prepares to fully launch into several markets and bring a new and safe antimicrobial solution to key markets,” stated Mario de la Guardia, chairperson of Seldox. “Christine’s many areas of expertise and knowledge will be critical to the organization as we start this exciting phase. Her success as a leader across key strategic areas, along with her long-standing professional relationships and approach to finding solutions, make her the right person for Seldox and we are fortunate to have her leading the team.”
Seldox’s technology has a strong history of research and development, with data generated across multiple microbes and environments. The technology offers, “The New Possible in Antimicrobial,” through its proprietary technology. The technology has antimicrobial applications in several industries, including healthcare, dentistry, water treatment, industrial coatings, and oil and gas. This proven technology offers companies looking for the new standard in antimicrobial solutions, the ability to partner with a trusted and scientifically researched product.
Seldox will have a booth at the upcoming MD &M Minneapolis, October 16th-17th, which will showcase the company’s proprietary technology. Visit booth #2316 to learn more about the new possible in antimicrobial solutions and talk with experts from the company regarding the extensive number of applications.
About Seldox
Seldox is a biotechnology company specializing in the prevention of biofilm formation using molecular additives of redox active selenium for medical, veterinary, dental, and industrial applications. The company is interested in establishing co-development or sub-licensing agreements with the goal of reaching long-term arrangements with companies that will commercialize products enhanced with Seldox technology. For more information about the New Possible in Antimicrobial, using Seldox’s technology, please visit www.seldox.com
Contact:
Christine Meidinger
[email protected]
651.361.0221
